Ładuje się......
Efficacy and safety of lopinavir-ritonavir in COVID-19: A systematic review of randomized controlled trials
BACKGROUND: Lopinavir-ritonavir is a repurposed drug for coronavirus disease-2019 (COVID-19). In this study, a pooled effect of lopinavir-ritonavir on mortality, virological cure, radiological improvement and safety profile in COVID-19 patients has been evaluated. METHODS: The databases were searche...
Zapisane w:
| Wydane w: | J Infect Public Health |
|---|---|
| Główni autorzy: | , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.
2021
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8056786/ https://ncbi.nlm.nih.gov/pubmed/34020215 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jiph.2021.03.015 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|